210 related articles for article (PubMed ID: 21143560)
21. Identification and Structural Analysis of New Nrf2 Activators by Mechanism-Based Chemical Transformation of 15-Deoxy-Δ
Kim K; Park JM; Kim NJ; Kim SJ; Moon H; An H; Lee J; Park HJ; Surh YJ; Suh YG
Chembiochem; 2016 Oct; 17(20):1900-1904. PubMed ID: 27453569
[TBL] [Abstract][Full Text] [Related]
22. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2.
Eggler AL; Liu G; Pezzuto JM; van Breemen RB; Mesecar AD
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10070-5. PubMed ID: 16006525
[TBL] [Abstract][Full Text] [Related]
23. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells.
Kim DH; Kim EH; Na HK; Surh YJ
Ann N Y Acad Sci; 2009 Aug; 1171():202-9. PubMed ID: 19723057
[TBL] [Abstract][Full Text] [Related]
24. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
[TBL] [Abstract][Full Text] [Related]
25. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.
Kim EH; Surh YJ
Biochem Pharmacol; 2006 Nov; 72(11):1516-28. PubMed ID: 16987499
[TBL] [Abstract][Full Text] [Related]
26. 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) protects neurons from oxidative death via an Nrf2 astrocyte-specific mechanism independent of PPARγ.
Haskew-Layton RE; Payappilly JB; Xu H; Bennett SA; Ratan RR
J Neurochem; 2013 Feb; 124(4):536-47. PubMed ID: 23199167
[TBL] [Abstract][Full Text] [Related]
27. Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase.
Yu X; Egner PA; Wakabayashi J; Wakabayashi N; Yamamoto M; Kensler TW
J Biol Chem; 2006 Sep; 281(36):26245-52. PubMed ID: 16857669
[TBL] [Abstract][Full Text] [Related]
28. 15-Deoxy-Δ(12,14)-prostaglandin J2 exerts pro- and anti-inflammatory effects in mesangial cells in a concentration-dependent manner.
Martínez AE; Sánchez-Gómez FJ; Díez-Dacal B; Oeste CL; Pérez-Sala D
Inflamm Allergy Drug Targets; 2012 Feb; 11(1):58-65. PubMed ID: 22309084
[TBL] [Abstract][Full Text] [Related]
29. Identification of compounds that inhibit the binding of Keap1a/Keap1b Kelch DGR domain with Nrf2 ETGE/DLG motifs in zebrafish.
Raghunath A; Nagarajan R; Sundarraj K; Palanisamy K; Perumal E
Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):259-270. PubMed ID: 30861618
[TBL] [Abstract][Full Text] [Related]
30. 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit.
Cernuda-Morollón E; Pineda-Molina E; Cañada FJ; Pérez-Sala D
J Biol Chem; 2001 Sep; 276(38):35530-6. PubMed ID: 11466314
[TBL] [Abstract][Full Text] [Related]
31. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells.
Hosoya T; Maruyama A; Kang MI; Kawatani Y; Shibata T; Uchida K; Warabi E; Noguchi N; Itoh K; Yamamoto M
J Biol Chem; 2005 Jul; 280(29):27244-50. PubMed ID: 15917255
[TBL] [Abstract][Full Text] [Related]
32. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification.
Kalantari P; Narayan V; Henderson AJ; Prabhu KS
FASEB J; 2009 Aug; 23(8):2366-73. PubMed ID: 19299483
[TBL] [Abstract][Full Text] [Related]
33. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
Cheron A; Peltier J; Perez J; Bellocq A; Fouqueray B; Baud L
J Immunol; 2004 Jun; 172(12):7677-83. PubMed ID: 15187150
[TBL] [Abstract][Full Text] [Related]
34. 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils.
Monneret G; Li H; Vasilescu J; Rokach J; Powell WS
J Immunol; 2002 Apr; 168(7):3563-9. PubMed ID: 11907120
[TBL] [Abstract][Full Text] [Related]
35. The omega-6 fatty acid derivative 15-deoxy-Δ¹²,¹⁴-prostaglandin J2 is involved in neuroprotection by enteric glial cells against oxidative stress.
Abdo H; Mahé MM; Derkinderen P; Bach-Ngohou K; Neunlist M; Lardeux B
J Physiol; 2012 Jun; 590(11):2739-50. PubMed ID: 22473776
[TBL] [Abstract][Full Text] [Related]
36. 15-Deoxy-Δ
Takagi T; Naito Y; Mizushima K; Hirai Y; Kamada K; Uchiyama K; Handa O; Ishikawa T; Itoh Y
Arch Biochem Biophys; 2019 Nov; 677():108183. PubMed ID: 31704099
[TBL] [Abstract][Full Text] [Related]
37. Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells.
Koppal T; Petrova TV; Van Eldik LJ
Brain Res; 2000 Jun; 867(1-2):115-21. PubMed ID: 10837804
[TBL] [Abstract][Full Text] [Related]
38. The glutathionylation of p65 modulates NF-κB activity in 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂-treated endothelial cells.
Lin YC; Huang GD; Hsieh CW; Wung BS
Free Radic Biol Med; 2012 May; 52(9):1844-53. PubMed ID: 22387200
[TBL] [Abstract][Full Text] [Related]
39. The chromatin-remodeling enzyme Smarca5 regulates erythrocyte aggregation via Keap1-Nrf2 signaling.
Ding Y; Li Y; Zhao Z; Cliff Zhang Q; Liu F
Elife; 2021 Oct; 10():. PubMed ID: 34698638
[TBL] [Abstract][Full Text] [Related]
40. 15-Deoxy-Delta(12,14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue.
Kim DH; Kim EH; Na HK; Sun Y; Surh YJ
Oncogene; 2010 Apr; 29(17):2560-76. PubMed ID: 20208557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
